Skip to content

Mobile Intervention Supervised Exercise Therapy Study 1

Mobile Intervention Supervised Exercise Therapy Study 1

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04832308
Acronym
MiSET-1
Enrollment
0
Registered
2021-04-05
Start date
2021-08-20
Completion date
2022-06-01
Last updated
2022-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Claudication, Intermittent, Peripheral Artery Disease

Brief summary

This is a randomized controlled trial evaluating the impact of the mobile phone delivered SVS SET Program on utilization, functional capacity, symptoms and quality of life.

Detailed description

This is a national randomized controlled study with approximately 10-15 sites enrolling patients with Rutherford II peripheral artery disease (PAD) in total. Patients will be randomized between the SVS SET Program and usual care for each site. The primary outcome will be to study the site-specific effect on utilization of exercise therapy. Secondary outcomes will be the effect on the 6-minute-walk test, passive activity and quality of life.

Interventions

BEHAVIORALExercise Therapy

This is a health coach driven exercise prescription for patients recommending 30 minutes or more of moderate effort walking 3-5 days a week with expected walk-rest-walk-rest intervals.

Sponsors

Society for Vascular Surgery
CollaboratorOTHER
Palo Alto Veterans Institute for Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Block randomization stratified by site.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of Age * Rutherford Class I-II PAD (claudication) * Ambulatory * Exercise Therapy Naive (\>18 mo) * Primary Owner of an Android or iOS device * Willingness to participate (text, call, fill out surveys) via a mobile phone

Exclusion criteria

* Symptomatic coronary artery disease * Oxygen dependent COPD * Significant osteoarthritis limiting ambulation

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Complete a 12-week Exercise Therapy Program12 weeks.Completion of a 12-week program in the treatment group will be completion of the remote SVS SET Program while the usual care group may have an in-person 12-week exercise therapy program.

Secondary

MeasureTime frameDescription
Mobile Phone Delivered 6-Minute Walk TestWeeks 0, 6 and 12Mobile-phone delivered 6-minute walk test result in steps to be reported at three time points.
Passive Activity as Measured on Mobile Device12 weeks.Daily passive step count activity as measured by sensors in mobile phone.
Quality of Life Survey as measured by the mini-Walking Impairment Questionnaire (mini-WIQ)Weeks 1, 6, and 12QoL questionnaires will be asked on the mobile phone at three time points.
Adherence as Measured by Completion of Scheduled Daily Walks12 weeks.Adherence to the recommended exercise therapy frequency (3 walks per week) and duration (for at least 30 minutes or more) will be measured
Freedom From Intervention as Measured by Absence of Surgical Intervention at One Year1 year.Freedom from any surgical intervention will be reported at one year by performing a chart review.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026